A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study

Authors:
  • LSLaurie Small
    Laurie Small

Abstract
No abstract available